N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide

C123H166Cl2N28O13 — CID 160566562

IUPACN-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide
SMILESCC(C)(C)OCC(=O)Nc1nc2ccc(Cl)nc2n1C1CCC1.CC(C)(C)OCCC(=O)Nc1nc2cccnc2n1C1CCC1.CC(C)CC(=O)Nc1nc2ccc(Cl)nc2n1C1CCC1.CC1(C)CC(CC(=O)Nc2nc3cccnc3n2C2CCC2)CCO1.CC1(C)CCC(CC(=O)Nc2nc3cccnc3n2C2CCC2)O1.CC1(C)CCCC(CC(=O)Nc2nc3cccnc3n2C2CCC2)O1.CC1(C)CCC[C@H](CC(=O)Nc2nc3cccnc3n2C2CCC2)O1
InChIInChI=1S/3C19H26N4O2.C18H24N4O2.C17H24N4O2.C16H21ClN4O2.C15H19ClN4O/c2*1-19(2)10-4-8-14(25-19)12-16(24)22-18-21-15-9-5-11-20-17(15)23(18)13-6-3-7-13;1-19(2)12-13(8-10-25-19)11-16(24)22-18-21-15-7-4-9-20-17(15)23(18)14-5-3-6-14;1-18(2)9-8-13(24-18)11-15(23)21-17-20-14-7-4-10-19-16(14)22(17)12-5-3-6-12;1-17(2,3)23-11-9-14(22)20-16-19-13-8-5-10-18-15(13)21(16)12-6-4-7-12;1-16(2,3)23-9-13(22)20-15-18-11-7-8-12(17)19-14(11)21(15)10-5-4-6-10;1-9(2)8-13(21)19-15-17-11-6-7-12(16)18-14(11)20(15)10-4-3-5-10/h2*5,9,11,13-14H,3-4,6-8,10,12H2,1-2H3,(H,21,22,24);4,7,9,13-14H,3,5-6,8,10-12H2,1-2H3,(H,21,22,24);4,7,10,12-13H,3,5-6,8-9,11H2,1-2H3,(H,20,21,23);5,8,10,12H,4,6-7,9,11H2,1-3H3,(H,19,20,22);7-8,10H,4-6,9H2,1-3H3,(H,18,20,22);6-7,9-10H,3-5,8H2,1-2H3,(H,17,19,21)/t14-;;;;;;/m1....../s1
InChIKeyQZZMOCVBTRGSDT-YEYOTXFRSA-N
MW2315.77 g/mol
LogP25.46
Rot. Bonds29

About N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide

N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide (PubChem CID 160566562) has the molecular formula C123H166Cl2N28O13 and a molecular weight of 2315.77 g/mol. Its IUPAC name is N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide.

Molecular Properties

Compound NameN-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide
PubChem CID160566562
Molecular FormulaC123H166Cl2N28O13
Molecular Weight2315.77 g/mol
Exact Mass2313.26
IUPAC NameN-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide
SMILESCC(C)(C)OCC(=O)Nc1nc2ccc(Cl)nc2n1C1CCC1.CC(C)(C)OCCC(=O)Nc1nc2cccnc2n1C1CCC1.CC(C)CC(=O)Nc1nc2ccc(Cl)nc2n1C1CCC1.CC1(C)CC(CC(=O)Nc2nc3cccnc3n2C2CCC2)CCO1.CC1(C)CCC(CC(=O)Nc2nc3cccnc3n2C2CCC2)O1.CC1(C)CCCC(CC(=O)Nc2nc3cccnc3n2C2CCC2)O1.CC1(C)CCC[C@H](CC(=O)Nc2nc3cccnc3n2C2CCC2)O1
InChIInChI=1S/3C19H26N4O2.C18H24N4O2.C17H24N4O2.C16H21ClN4O2.C15H19ClN4O/c2*1-19(2)10-4-8-14(25-19)12-16(24)22-18-21-15-9-5-11-20-17(15)23(18)13-6-3-7-13;1-19(2)12-13(8-10-25-19)11-16(24)22-18-21-15-7-4-9-20-17(15)23(18)14-5-3-6-14;1-18(2)9-8-13(24-18)11-15(23)21-17-20-14-7-4-10-19-16(14)22(17)12-5-3-6-12;1-17(2,3)23-11-9-14(22)20-16-19-13-8-5-10-18-15(13)21(16)12-6-4-7-12;1-16(2,3)23-9-13(22)20-15-18-11-7-8-12(17)19-14(11)21(15)10-5-4-6-10;1-9(2)8-13(21)19-15-17-11-6-7-12(16)18-14(11)20(15)10-4-3-5-10/h2*5,9,11,13-14H,3-4,6-8,10,12H2,1-2H3,(H,21,22,24);4,7,9,13-14H,3,5-6,8,10-12H2,1-2H3,(H,21,22,24);4,7,10,12-13H,3,5-6,8-9,11H2,1-2H3,(H,20,21,23);5,8,10,12H,4,6-7,9,11H2,1-3H3,(H,19,20,22);7-8,10H,4-6,9H2,1-3H3,(H,18,20,22);6-7,9-10H,3-5,8H2,1-2H3,(H,17,19,21)/t14-;;;;;;/m1....../s1
InChIKeyQZZMOCVBTRGSDT-YEYOTXFRSA-N
XLogP25.46
TPSA474.05 Ų
H-Bond Donors7
H-Bond Acceptors34
Rotatable Bonds29
Heavy Atoms166
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002315.77
LogP ≤ 525.46
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1034

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide?
The IUPAC name of N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide (CID 160566562) is N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide.
What is the SMILES notation for N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide?
The canonical SMILES for N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide is CC(C)(C)OCC(=O)Nc1nc2ccc(Cl)nc2n1C1CCC1.CC(C)(C)OCCC(=O)Nc1nc2cccnc2n1C1CCC1.CC(C)CC(=O)Nc1nc2ccc(Cl)nc2n1C1CCC1.CC1(C)CC(CC(=O)Nc2nc3cccnc3n2C2CCC2)CCO1.CC1(C)CCC(CC(=O)Nc2nc3cccnc3n2C2CCC2)O1.CC1(C)CCCC(CC(=O)Nc2nc3cccnc3n2C2CCC2)O1.CC1(C)CCC[C@H](CC(=O)Nc2nc3cccnc3n2C2CCC2)O1.
What is the InChIKey of N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide?
The InChIKey is QZZMOCVBTRGSDT-YEYOTXFRSA-N. The full InChI is InChI=1S/3C19H26N4O2.C18H24N4O2.C17H24N4O2.C16H21ClN4O2.C15H19ClN4O/c2*1-19(2)10-4-8-14(25-19)12-16(24)22-18-21-15-9-5-11-20-17(15)23(18)13-6-3-7-13;1-19(2)12-13(8-10-25-19)11-16(24)22-18-21-15-7-4-9-20-17(15)23(18)14-5-3-6-14;1-18(2)9-8-13(24-18)11-15(23)21-17-20-14-7-4-10-19-16(14)22(17)12-5-3-6-12;1-17(2,3)23-11-9-14(22)20-16-19-13-8-5-10-18-15(13)21(16)12-6-4-7-12;1-16(2,3)23-9-13(22)20-15-18-11-7-8-12(17)19-14(11)21(15)10-5-4-6-10;1-9(2)8-13(21)19-15-17-11-6-7-12(16)18-14(11)20(15)10-4-3-5-10/h2*5,9,11,13-14H,3-4,6-8,10,12H2,1-2H3,(H,21,22,24);4,7,9,13-14H,3,5-6,8,10-12H2,1-2H3,(H,21,22,24);4,7,10,12-13H,3,5-6,8-9,11H2,1-2H3,(H,20,21,23);5,8,10,12H,4,6-7,9,11H2,1-3H3,(H,19,20,22);7-8,10H,4-6,9H2,1-3H3,(H,18,20,22);6-7,9-10H,3-5,8H2,1-2H3,(H,17,19,21)/t14-;;;;;;/m1....../s1.
What are the key properties of N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide?
N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide has a molecular weight of 2315.77 g/mol, XLogP of 25.46, 29 rotatable bonds, 7 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-methylbutanamide;N-(5-chloro-3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2-methylpropan-2-yl)oxy]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(2,2-dimethyloxan-4-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-[(2R)-6,6-dimethyloxan-2-yl]acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(6,6-dimethyloxan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-2-(5,5-dimethyloxolan-2-yl)acetamide;N-(3-cyclobutylimidazo[4,5-b]pyridin-2-yl)-3-[(2-methylpropan-2-yl)oxy]propanamide is sourced from PubChem (CID 160566562), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).